Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 4/2018

01.08.2018 | Research Article

Prevalence and characteristics of hospital inpatients with reported fluoroquinolone allergy

verfasst von: Geoffrey C. Wall, Matthew J. Taylor, Hayden L. Smith

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Background Fluoroquinolone (quinolones) antibiotics are commonly prescribed worldwide. Hypersensitivity reactions to these agents have been reported, but little systematic data exists concerning prevalence, types of reactions, or associated factors. Objective To identify the prevalence of patients reporting an allergy to quinolones, types of reactions claimed, and patient information associated with allergy. Setting A tertiary 370 bed level 1 trauma center, located in a Midwestern City in the United States. Method A retrospective cohort study was conducted. Included in the study were all unique patients 18 years or older admitted to our hospital in 2016 with a length of stay ≥ 24 h. Collected data elements included types of reaction, other drug allergies claimed, and patient characteristics. As a comparator group, an equal sized random sample of patients admitted during the same period reporting penicillin allergy was identified. Main Outcome Measure prevalence and descriptors of quinolone allergy. Results There were 327 patients with a quinolone allergy and 317 patients with a penicillin allergy used as the study sample. Hospital prevalence rate for quinolone allergy was 2%. Hives, rash, and nausea/vomiting were the most common reported reactions. These patients tended to be older than penicillin allergy patients and had an association with concomitant intravenous contrast allergy. Tendonitis or tendon rupture was reported in quinolone patients. Conclusion The prevalence of patients claiming a quinolone allergy in the study hospital was 2%. Common hypersensitivity reactions were reported. Data tended to support a possible association between intravenous contrast allergy and quinolone allergy.
Literatur
1.
Zurück zum Zitat Trubiano J, Phillips E. Antimicrobial stewardship’s new weapon? A review of antibiotic allergy and pathways to ‘de-labeling’. Curr Opin Infect Dis. 2013;26:526–37.CrossRef Trubiano J, Phillips E. Antimicrobial stewardship’s new weapon? A review of antibiotic allergy and pathways to ‘de-labeling’. Curr Opin Infect Dis. 2013;26:526–37.CrossRef
2.
Zurück zum Zitat Picard M, Bégin P, Bouchard H, Cloutier J, Lacombe-Barrios J, Paradis J, et al. Treatment of patients with a history of penicillin allergy in a large tertiary-care academic hospital. J Allergy Clin Immunol Pract. 2013;1:252–7.CrossRef Picard M, Bégin P, Bouchard H, Cloutier J, Lacombe-Barrios J, Paradis J, et al. Treatment of patients with a history of penicillin allergy in a large tertiary-care academic hospital. J Allergy Clin Immunol Pract. 2013;1:252–7.CrossRef
3.
Zurück zum Zitat Swearingen SM, White C, Weidert S, Hinds M, Narro JP, Guarascio AJ, et al. A multidimensional antimicrobial stewardship intervention targeting aztreonam use in patients with a reported penicillin allergy. Int J Clin Pharm. 2016;38:213–7.CrossRef Swearingen SM, White C, Weidert S, Hinds M, Narro JP, Guarascio AJ, et al. A multidimensional antimicrobial stewardship intervention targeting aztreonam use in patients with a reported penicillin allergy. Int J Clin Pharm. 2016;38:213–7.CrossRef
5.
Zurück zum Zitat Seitz CS, Bröcker EB, Trautmann A. Diagnostic testing in suspected fluoroquinolone hypersensitivity. Clin Exp Allergy. 2009;39:1738–45.CrossRef Seitz CS, Bröcker EB, Trautmann A. Diagnostic testing in suspected fluoroquinolone hypersensitivity. Clin Exp Allergy. 2009;39:1738–45.CrossRef
6.
Zurück zum Zitat Blanca-López N, Andreu I, Torres Jaén MJ. Hypersensitivity reactions to quinolones. Curr Opin Allergy Clin Immunol. 2011;11:285–91.CrossRef Blanca-López N, Andreu I, Torres Jaén MJ. Hypersensitivity reactions to quinolones. Curr Opin Allergy Clin Immunol. 2011;11:285–91.CrossRef
7.
Zurück zum Zitat Blanca-López N, Ariza A, Doña I, Mayorga C, Montañez MI, Garcia-Campos J, et al. Hypersensitivity reactions to fluoroquinolones: analysis of the factors involved. Clin Exp Allergy. 2013;43:560–7.CrossRef Blanca-López N, Ariza A, Doña I, Mayorga C, Montañez MI, Garcia-Campos J, et al. Hypersensitivity reactions to fluoroquinolones: analysis of the factors involved. Clin Exp Allergy. 2013;43:560–7.CrossRef
8.
Zurück zum Zitat Noel GJ, Bradley JS, Kauffman RE, Duffy CM, Gerbino PG, Arguedas A, et al. Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders. Pediatr Infect Dis J. 2007;26:879–91.CrossRef Noel GJ, Bradley JS, Kauffman RE, Duffy CM, Gerbino PG, Arguedas A, et al. Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders. Pediatr Infect Dis J. 2007;26:879–91.CrossRef
9.
Zurück zum Zitat Pichler WJ, Srinoulprasert Y, Yun J, Hausmann O. Multiple drug hypersensitivity. Int Arch Allergy Immunol. 2017;172:129–38.CrossRef Pichler WJ, Srinoulprasert Y, Yun J, Hausmann O. Multiple drug hypersensitivity. Int Arch Allergy Immunol. 2017;172:129–38.CrossRef
10.
Zurück zum Zitat Szebeni J. Hypersensitivity reactions to radiocontrast media: the role of complement activation. Curr Allergy Asthma Rep. 2004;4:25–30.CrossRef Szebeni J. Hypersensitivity reactions to radiocontrast media: the role of complement activation. Curr Allergy Asthma Rep. 2004;4:25–30.CrossRef
11.
Zurück zum Zitat Kelesidis T, Fleisher J, Tsiodras S. Anaphylactoid reaction considered ciprofloxacin related: a case report and literature review. Clin Ther. 2010;32:515–26.CrossRef Kelesidis T, Fleisher J, Tsiodras S. Anaphylactoid reaction considered ciprofloxacin related: a case report and literature review. Clin Ther. 2010;32:515–26.CrossRef
12.
Zurück zum Zitat Liu HH. Safety profile of the fluoroquinolones. Drug Saf. 2010;33:353–69.CrossRef Liu HH. Safety profile of the fluoroquinolones. Drug Saf. 2010;33:353–69.CrossRef
13.
Zurück zum Zitat Perez E, Callero A, Martinez-Tadeo JA, Hernandez G, Rodríguez-Plata E, Almeida Z, et al. Are skin tests useful in fluoroquinolone hypersensitivity diagnosis? Ann Allergy Asthma Immunol. 2013;111:423–5.CrossRef Perez E, Callero A, Martinez-Tadeo JA, Hernandez G, Rodríguez-Plata E, Almeida Z, et al. Are skin tests useful in fluoroquinolone hypersensitivity diagnosis? Ann Allergy Asthma Immunol. 2013;111:423–5.CrossRef
14.
Zurück zum Zitat Scherer K, Bircher AJ. Hypersensitivity reactions to fluoroquinolones. Curr Allergy Asthma Rep. 2005;5:15–21.CrossRef Scherer K, Bircher AJ. Hypersensitivity reactions to fluoroquinolones. Curr Allergy Asthma Rep. 2005;5:15–21.CrossRef
Metadaten
Titel
Prevalence and characteristics of hospital inpatients with reported fluoroquinolone allergy
verfasst von
Geoffrey C. Wall
Matthew J. Taylor
Hayden L. Smith
Publikationsdatum
01.08.2018
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 4/2018
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-018-0613-0

Weitere Artikel der Ausgabe 4/2018

International Journal of Clinical Pharmacy 4/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.